免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

多糖止血粉(HP-2,HP-3,HP-5)

K号: K240097 · 2024-05-22

决定日期2024-05-22
产品代码QSY
决定实质等同

器械摘要

Polysaccharide Hemostatic Powder (HP-2, HP-3, HP-5) is the device name listed in this FDA 510(k) record. The listed applicant is Ushare Medical, Inc.. It received FDA 510(k) clearance on 2024-05-22 under 510(k) number K240097. The device is classified under product code QSY. FDA Decision: Substantially Equivalent.

常见问题

What is the Polysaccharide Hemostatic Powder (HP-2, HP-3, HP-5)?

Polysaccharide Hemostatic Powder (HP-2, HP-3, HP-5) is a medical device that received FDA 510(k) clearance on 2024-05-22. The listed applicant is Ushare Medical, Inc.. The 510(k) number is K240097.

When did Polysaccharide Hemostatic Powder (HP-2, HP-3, HP-5) receive FDA 510(k) clearance?

Polysaccharide Hemostatic Powder (HP-2, HP-3, HP-5) received FDA 510(k) clearance on 2024-05-22, under 510(k) number K240097.

Who is the listed applicant for Polysaccharide Hemostatic Powder (HP-2, HP-3, HP-5)?

The FDA 510(k) record lists Ushare Medical, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Polysaccharide Hemostatic Powder (HP-2, HP-3, HP-5)?

The FDA product code for Polysaccharide Hemostatic Powder (HP-2, HP-3, HP-5) is QSY.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

列明Ushare Medical, Inc.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:QSY)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑